Firefly Neuroscience (AIFF) Enterprise Value (2010 - 2026)

Firefly Neuroscience has reported Enterprise Value for 17 years, with the latest figure at $15.7 million in Q2 2026.

• On a quarterly basis, Enterprise Value fell 50.58% year-over-year to $15.7 million in Q2 2026; TTM through Jun 2026 was $15.7 million, a 50.58% decrease from a year earlier, with the FY2025 full-year figure at $9.5 million, down 38.6% from the prior year.
• Enterprise Value was $15.7 million for Q2 2026 at Firefly Neuroscience, down from $29.3 million in the prior quarter.
• The five-year high for Enterprise Value was $88.6 million in Q1 2022, with the low at $1.3 million in Q4 2023.
• Average Enterprise Value over 5 years is $21.6 million, with a median of $16.3 million recorded in 2022.
• The sharpest annual moves came in 2023 and 2024: Enterprise Value tumbled 94.61% in 2023, then surged 1133.99% in 2024.
• Over 5 years, Enterprise Value stood at $9.1 million in 2022, then tumbled by 86.22% to $1.3 million in 2023, then soared by 1133.99% to $15.5 million in 2024, then tumbled by 38.6% to $9.5 million in 2025, then surged by 64.27% to $15.7 million in 2026.
• The last three Enterprise Value figures came in at $15.7 million (Q2 2026), $29.3 million (Q1 2026), and $9.5 million (Q4 2025), per Business Quant data.